BiotechTube
Home/Alentis Therapeutics/Prof. Thomas Baumert
PT

Prof. Thomas Baumert

Founder

Alentis Therapeutics

Therapeutic Areas

OncologyFibrosis

Alentis Therapeutics Pipeline

DrugIndicationPhase
ALE.P02Squamous CancersPhase 1/2
Lixudebart (ALE.F02)Organ FibrosisPhase 2
ALE.P03Not SpecifiedPreclinical

Leadership Team at Alentis Therapeutics

MP
Mark Pruzanski
Chief Executive Officer
LM
Luigi Manenti
Chief Medical Officer
View full Alentis Therapeutics profile